COL18A1 and cancer: Most of the studies using endostatin for the treatment of different types of cancer focus on patients with advanced stage disease, mostly stage III-IV, in order to evaluate whether this agent is able to improve survival and also have an acceptable safety profile that does not result in treatment discontinuation.